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INTRODUCTION AND LITERATURE REVIEW
The separation of a sample from impurities is critical to the success of an analysis.
By definition, separation is the hypothetical condition where there is complete isolation,
by m separate macroscopic regions, of each of the m chemical components which
comprise a mixture.In other words, the goal of any separation process is to isolate the
m chemical components into m vessels, such as glass vials or polyethylene bottles (28).
The separation method must be rapid, reliable and reproducible.
Chromatography is a separation technique where one phase is held immobile
(stationary phase) and the other phase (mobile phase) is passed over it (22).Key
developments in chromatography are summarized in Table1.Chromatographic
separations are based on different rates of migration of solutes between the stationary
phase and the mobile phase. Initially, a mixture is introduced into the system and carried
by the mobile phase. Then, components in the mixture equilibrate or partition between
the two phases, resulting in separation of the compounds (Figure1).Different
chromatography modes are classified based on the stationary phase and mobile phase
(Table 2).2
Table 1. Key developments in chromatography.
1906 Development of planar chromatography: thin layer chromatography (TLC)
using silica gel as the planar support (17)
Tswett (Russian Botanist) known as the Father of Chromatography
described the separation of plant pigments by column liquid
chromatography (4,8,22,25)
1940 Martin and Synge published their Noble Prize-winning paper about liquid-
liquid (partition) chromatography and proposed the plate theory (25)
1950 Craigpublishedapaperentitled"PartitionChromatography and
Countercurrent Distribution" (6)
1952 Martin and Synge published a paper about gas chromatography for the
separation of volatile fatty acids (21,22,25)
1955 Glueckauf published a paper entitled "The Plate Concept in Column
Separation" (22)
van Deemter, Zuiderweg and Klinkenberg proposed rate theory, the van
Deemter plot, described chromatographic processes in terms of kinetics, and
examined diffusion and mass transfer (32)
1963 Giddings published a paper entitled"Liquid Chromatography with
Operating Conditions Analogous to Those of Gas Chromatography" (10)
High performance liquid chromatography (HPLC) was developed and has
been extensively used since then (10,22,31)id-
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High performance liquid chromatography (HPLC)
Highperformanceliquidchromatography(HPLC)ormodernliquid
chromatography (LC) is an analytical technique that has been used sincethe late 1960's
(Table 1).The main operational requirement of HPLC is the use of high pressure to
enable the rapid diffusion rate of sample through the small uniformpacking particle
which results in fast analysis times (11).Figure 2 shows the basic components of an
HPLC system.A single pump issufficient for an isocratic analysis where the
composition of mobile phase is constant.On the other hand, to perform a gradient
analysis an additional pump is needed to pump a different solvent into amixing chamber
in order to vary the mobile phase composition (25).
Classical LC and HPLC are compared in Figure 3, and the differencesbetween
these two techniques are discussed below:
Classical LC and HPLC (30)
In classical LC a column is used only once, and therefore packing a
column (step 1, bed preparation) has to be repeated. Sample application(step 2) requires
skill and time on the part of the operator. Solvent flow (step 3)is achieved by gravity,
and detection and quantitation (step 4) are achieved by the manualanalysis of individual
fractions.6
Many separations, however, can be carried out on a given HPLC column since a
closed, reusable column is used (step 1).Sample application (step 2) can be precisely
performed without difficulty either by syringe injection or sample loop.Solvent flow
(step 3) is achieved by using high pressure pumps, which give controlled and rapid flow
of solvent resulting in reproducible operation with excellent accuracy.Detection and
quantitation (step 4) are performed by an on-line detector which provides continuous
chromatograms without intervention by an operator.Thus an accurate record of a
separation can be obtained with minimum effort.
Classical LC is principally a preparative technique, while HPLC can be used for
both analytical and preparative separations. The major advantages of HPLC over classical
LC are the high speed, the enhancement of resolution and the high sensitivity of detection
methods. HPLC, however, is much more expensive than classical LC which often limits
the size of a purchased column and therefore limits the scale of a sample separation.Solvent
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High performance liquid chromatography of peptides
The application of HPLC to peptide purification has been successfully employed
for years since the method is very effective and reliable (7,13,20).The optimum
conditions for purification, however, depend on an individual peptide's characteristics,
including polarity, basicity, and molecular weight, and many factors can affect the
separation of the desired peptides from impurities.First, the type of chromatography
must be chosen. The three main modes of HPLC used for peptide separations utilize
differences in peptide size (size exclusion HPLC or SEC), net charge (ion-exchange
HPLC or IEC) and hydrophobicity (reverse phase HPLC or RPC) (Figure 4).In this
study, only RPC and IEC are discussed in detail since the sizes of the desired peptides
and the byproducts are similar.
Figure 4. Schematic illustration of orthogonality in chromatographic separations (19).10
Second, the stationary phase, which can vary in composition, particle size and pore
size, has to be chosen. Finally, the mobile phase composition, including organicmodifier,
ion-pairing agent and pH, are examined to obtain optimum conditions for separation.
Reverse phase chromatography (RPC)
Reverse phase chromatography is a form of partition chromatography where the
chemically bonded-phase (stationary phase) is hydrophobic or non-polar (e.g. octadecyl
groups) and the starting mobile phase (e.g. water) is more polar.Separations by RPC
involve differences in solute hydrophobicities. The most polar molecules will havethe
weakest interactions with the hydrophobic stationary phase, and thus have thesmallest
retention volumes and shortest retention times (17).
Peptides are comprised of amino acids which contain both hydrophilic (e.g.-NH3+,
-COO- and -OH) and hydrophobic (e.g. aliphatic or aromatic hydrocarbon sidechains)
groups. Reverse phase chromatographywith an aqueous mobile phase is appropriate to
purify peptide mixtures since peptides are retained essentially according to their
hydrophobic character.During separation, peptides exhibit regular reverse phase
behaviors with a water-rich eluent of low pH and low ionic strength. Peptides areinitially
adsorbed on to the stationary phase and subsequently solvated by the solvent. Peptides
remain on the support until there is a high enough concentration of organic modifier to
displace or desorb the peptides from the support.This is the adsorption/displacement
mechanism of interaction of peptides with a hydrophobic reverse-phase surface.11
The commonly used columns in RPC contain a silica-based support (Figure 5),
which can be functionalized by attachment of hydrocarbon chains to the hydroxyl side
chains. Four media for RPC columns and their applications for peptide separations are
summarized in Table 3.
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Figure 5.Structure of silica-based support (16).
Organic solvents used in the mobile phase for RPC must be chemically and
physically compatible with the solute, the material used in the column support, the solvent
delivery system and the detector. Mobile phase of low viscosity is favored since it can
be run at a wide range of flow rates without high backpressure. Methanol, acetonitrile
and 1- or 2-propanol are popular solvents used for peptide separations, although other
water-miscible,UV-transparentsolvents(e.g.methoxyethanol,ethanol,butanol,12
tetrahydrofuran or dioxane) are also employed (7). Ion-pairing agents (e.g. trifluoroacetic
acid (TFA), heptafluorobutyric acid (HFBA) or phosphoric acid (H3PO4)) are usually
added to the mobile phase to displace peptides from the stationary phase.
The mobile phase pH has significant effects on peptide retention, since retention
is dependent on the ionization states of free amino and carboxyl groups.Hydrophobic
or non-polar peptides are retained on thehydrophobic surface of RPC; therefore a change
in pH that increases the ionization of a peptide will enhance its polarity andshorten its
retention time. On the other hand, decreasing the ionization state of a peptidereduces
peptide polarity and lengthens its retention time.
Table 3. Media for RPC columns (14).
Media
C4
C8
C18
Diphenyl
Applications
For large peptides (greater than 20-30 residues), CNBr fragments
and hydrophobic polypeptides
Peptide maps, natural and synthetic peptides and small hydrophilic
protein
Enzymatic maps and small peptides
Polypeptides containing aromatic sidechains13
Ion-exchange chromatography (IEC)
Reverse phase chromatography is a widely used technique for purificationof
peptides, but there are cases where RPC is impractical. These include the separationof
peptides which are extremely hydrophobic or hydrophilic and peptides whichcontain
many charged amino acids (e.g. aspartic acid,glutamic acid, arginine, lysine and
histidine).The very hydrophobic peptides are retained on non-polar surface of RPC,
resulting in unreasonably long retention times, while hydrophilic or charged peptides are
too polar to be held by the RPC stationary phase.In both cases, separation of the
peptides cannot be achieved and aggregation of these peptides in the mobile phase may
occur due to hydrophobic or electrostaticinteractions (1).
Ion-exchange chromatography can be employed when RPC is not applicable, since
separations by IEC are based on differences in peptide net charge.Anion-exchange
(AEX) is useful for peptides containing acid residues (e.g. aspartic and glutamicacid),
whereas cation-exchange (CEX) is useful for peptides containing basic residues(e.g.
arginine, lysine and histidine) (20).
Stationary phases of IEC consist of bound ions and oppositely charged counter-
ions (Figure 6); ionized solutes are retained by displacing the counterions.Peptide
separations occur as a result of differences in the relative affinity of the peptide for the
stationary phase ions as compared to the affinity of the mobile phase counterions in a
system involving dynamic exchange (25,31).Electrostatic attraction is a major force
between mobile phase ions, both charged peptides and eluents, and the ion centers onthe14
stationary phase.
IEC stationary phases or resins are composed of either silica or a polymer (e.g.
divinylbenzene in a polystyrene matric) containing different functional groups, depending
upon the type of exchanged ion (Table 4).Silica-based supports are rigid but readily
dissolve at high pH (pH > 8.0), while polymeric supports possess greater pH stability
(15,23).
The solvents used in the IEC mobile phase must meet the same requirements as
those used in RPC mobile phases, including compatibility with solutes and the HPLC
system, low viscosity and UV transparency. The most widely used solvents arephosphate
or acetate buffers.Salt counter-ions are added to displace solute ions from the charged
sites on the stationary phase. Different salts exhibit distinct effects on peptide retentions;
divalent salts are stronger displacers than monovalent salts, and smaller ions are also
stronger than larger ions. The order of decreasing elution strengths of commonlyused
salts are (23):
cations: Mg2+ > Ca2+ > NH4+ > Na+ > 1(÷
anion: 5042-HP042- > Cl > CH3C00-
Amino acids are amphoteric molecules containing both positive and negative
charges. Therefore, manipulating the pH of the mobile phase will alter the net charge of
peptides.The pH of the mobile phase should be at least 0.5 pH units above the
isoelectric point (pI) of the peptide for AEX and below the pI for CEX (23).15
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Figure 6. Structure of an ion-exchange resin (25).
Table 4. Common types of ion-exchange resins (2).
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OBJECTIVES
Research in our laboratory involves preparing analogues of the opioid peptide
dynorphin A, which is thought to be an endogenous ligand for x opioid receptors (5).
Constrained cyclic analogues are being prepared to explore possible biologically active
conformations at these receptors.During the preparation of one series of cyclic
analogues, cyclo[D- Asp2,X5]Dyn A (1-13)NH2, where X isornithine (Orn), a,y-
diaminobutyric acid (Dab) or a, P-diaminopropinoic acid (Dap) (Figure 7, (I)), different
side products were obtained depending upon the activation reagent used for the
cyclization(ArttamangkulandAldrich,manuscriptinpreparation). The
tetramethylguanidinium (Tmg) derivative, [D-Asp2,X (Tmg)5]Dyn A(1-13)NH2 (Figure 7,
(II)) was the major side product when 2-(1-H-benzotriazo-1-y1)-1,1,3,3 tetramethyluronium
hexafluorophosphate (HBTU) (9,18) was used, whereas thelinear peptide,[D-
Asp2,X5]Dyn A (1-13)NH2 (Figure 7, (III)), was obtained as the only side product when
other reagents (benzotriazolyl-N-oxytridimethylaminophosphonium hexafluoro-phosphate
(BOP)(29) or diisopropyl carbodiimide (29)) were used. The unusual Tmg derivatives
resulted from transferring of the tetramethyluronium group from HBTU to the side chain
amine.
The following study focuses on using high performance liquid chromatography
(HPLC) to separate the cyclic dynorphin A analogues, cyclo[D-Asp2,X5[Dyn A (1-13)NH2
from the Tmg side product. Two modes of HPLC, reverse phase (RPC) and ion-exchange
(IEC) chromatography, were examined under various conditions utilizing different pHs,17
organic modifiers and ion-pairing agents. These factors were varied toobtain optimum
conditions for purification of the cyclic peptides on a preparativescale. All results from
the separation of ornithine analogue are discussed and selected resultsfor other analogues
(diaminobutyric acid and diaminopropionic acid) are shown in theappendices.HO
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Figure 7. Structure of cyclo[D-Asp2,X5JDyn A (1-13)NH2 (I), [D-Asp2,X(Tmg)5]Dyn A
(1-13)NH2 (II) and [D-Asp2,X1Dyn A (1-13)NH2 (III) analogues.19
EXPERIMENTAL METHODS
Equipment and materials
The HPLC system consisted of two Beckman 110B pumps, a 421A controller, a
163 variable wavelength detector model 334, injector with a 20 pt or 500 pL (for the
loading studies) loop, and a Waters 740 data module integrator. Eluents were monitored
at 214 nm for mobile phase systems 1, 4-6 and 8 and at 225 nm for systems 2 and 7
(Table 5). Loading studies were monitored at 280 nm. Separations were carried out on
three reverse phase columns and one ion exchange column. The Vydac column (The
Separation Group, Hespernia, CA), Zorbax Protein Plus column (DuPont, Wilmington,
DE), and Dynamax column (Rainin, Emeryville, CA) are reverse phase columns
containing spherical butyl-bonded (C4) silica as the stationary phase. The strong cation
exchange (SCX) column (The Nest Group, Southborough, MA) consists of polysulfoethyl
aspartamide polymeric surfaces (Figure 8). For all of the columns the dimensions were
4.6 x 25 mm except for the SCX guard cartridge, which was 4.6 x 50 mm and the
stationary phase had a 5 pm particle size (except for the Zorbax column, which was 10
p.m) and 300 A pore size.
Solvents and reagents used for HPLC were obtained from the following sources:
acetonitrile-UVand methanol(Burdick & Jackson,Muskegon,MI);IonateTM
trifluoroacetic acid (TFA), heptafluorobutyric acid (HBFA) and triethylamine (TEA)
(Pierce Chemical Co., Rockville, IL).Other reagents were reagent grade: KC1 and20
KH2PO4 (Mallinckrodt, Paris, KY); H3PO4 (J T Baker Chemical, Phillipsburg, NJ). Water
was obtained from a Millipore Mill Q System (Collegeof Pharmacy) and all mobile
phases were filtered through a 0.45 µm Nylaflo membrane (Gelman Science, Ann Arbor,
MI) and degassed before used.
Procedure
Peptides were synthesized as described elsewhere (Arttamangkul and Aldrich,
manuscript in preparation). Crude peptides A, B and C in Table 6 (structures shown in
Figure 7), and pure cyclic, Tmg and linear derivatives of each peptide were dissolved in
water to give a concentration of 1 mg/mL. HPLC analyses were performed on reverse
phase columns using a standard gradient of 0%-75% of solvent B (Table 5) over 50 min
with flow a rate of 1.5 mL/min. The effects of ion-pairing agents and organic modifiers
were studied by using the mobile phase systems describedin Table6.The
triethylammonium phosphate (TEAP) buffers I and II were obtained by bringing the pH
of 0.25 N and 0.09 N phosphoric acid solutions, respectively, to 2.5 with triethylamine
(27). A loading study of 1 and 3 mg of crude peptide A was investigated on Zorbax
column using TEAP II buffer. Method development for separation on the SCX column
was done on a guard cartridge (4.6 x 50 mm)by varying the percent of acetonitrile and
the pH of the mobile phase.The best conditions were chosen to separate the crude
peptides on the analytical column. The loading capacity of the analytical column was
also studied using 1, 5 and 10 mg of crude peptide A.21
Table 5. Composition of the mobile phases for HPLC"
System Solvent A Solvent B
1 0.1% TFA in H2O 0.1% TFA in AcCN
2 0.1% TFA in H2O 0.1% TFA in Me0H
3 0.1% HFBA in H2O 0.1% HFBA in AcCN
4 0.1% H3PO4 in H2O 0.1% H3PO4 in AcCN
5 TEAP(I) AcCN
6 TEAP(II) 40%A + 60% AcCN
7 TEAP(I) Me0H
8 5 mM KH2PO4 in x% AcCN A + 800 mM KCl
'Systems 1 through 7 were used for reverse phase HPLC and system 8 was used for ion-
exchange chromatography.
2TFA=trifluoroaceticacid;HFBA =heptafluorobutyricacid;TEAP(I)=
triethylammonium phosphatebuffer(0.25 N H3PO4 in TEA/H20); TEAP(II) =
triethylammonium phosphate buffer (0.09 N H3PO4 in TEA/H20); TEA = triethylamine;
x% = 10%, 20% or 35%22
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Figure 8.Stationary phase of SCX column (polysulfoethyl aspartamide) (1).
Table 6. Synthetic peptides studied.
Crude peptide Composition
A cyclic and Tmg [D- Asp2,Orn5]Dyn A (1-13)NH2
B cyclic and Tmg [D-Asp2,Dab5]Dyn A (1-13)NH2
C cyclic and Tmg [D-Asp2,Dap5]Dyn A (1-13)NH2
Tmg = trimethylguanidinium; Dab = diaminobutyric acid; Dap =diaminopropionic
acid.23
Calculations
The degree of separation is defined as the resolution value (Rs) which is calculated
from equation (a) when components in a sample are well resolved and there is no baseline
drift (Figure 9a). Larger values of Rs mean better separation, and smaller values of Rs
indicate poorer separation.
RS= (t20/0.5 (W2 + WI) (a)
where to t2 = elution times and WI, W2 = baseline peak widths in minutes of the
first and second peak, respectively, in the chromatogram (30) (Figure 9a).
The separation of a real sample is usually complicated by baseline drift and minor
impurities(Figure 9b), which can make it difficult to measure baseline peak widths. The
more accurate Rs values are obtained by using equation (b) (23), where W, and W2 are
peak widths at half height in minutes (Figure 9b).
Rs = 1.18 (t2ti) /(W2 + WI) (b)
Resolution values shown on the chromatograms and the discussion of the results
in this study are based on calculations using equation (b).Comparisons of purified
peptide retention times under the HPLC conditions used for separation of crude peptide
A are shown in Tables 8.1 and 8.2.Tables 9.1 and 9.2 summarize the Rs values
calculated from both equations (a) and (b) for the cyclic and Tmg peptides from
separation of crude peptide A under various HPLC conditions.24
a)
b)
Rs = 2 (t2 - t1)
(W2 + W1)
Rs = 1.18 (t2- t1)
(W2 +
t2
t
Figure 9. Resolution in HPLC: a) ideal sample and b) real sample (23,30).25
RESULTS AND DISCUSSION
Reverse phase chromatography
Comparison by standard RPC condition (0.1% TFA in aqueous AcCN) of [D-
Asp2,Orn5]Dyn A (1-13)NH2 cyclized with HBTU indicated that the Tmg side product (tR
= 16.2 min) was more difficult to separate from the cyclicpeptide (tR = 18.2 min) (Figure
10a) than was the separation of the linear peptide (tR = 14.8 min) (Table 8.1) from the
cyclic peptide.Therefore, the separation of desired cyclic peptide from the Tmg
byproduct was examined by RPC under various conditions. The effects of several ion-
pairing agents, pH and different organic solvents (e.g. AcCN and Me0H) were studied.
Effect of ion-pairing agents
In RPC, peptides are initially adsorbed on hydrophobic surfaces of the stationary
phase and subsequently desorbed by the organic solvent (12).Since they are typically
charged molecules at pHs used in chromatography, different counterions will influence
their chromatographic behavior, and changing the ion-pairing agent may improve
resolution.Anionic counterions (e.g. TFA, HFBA and H3PO4) interact with ionized
residues within the peptide and affect its retention. Ion-pairing agents such as TEAP and
H3PO4 can be used, but a desalting step is required in the final purification process
(26,27).26
Although TFA is routinely used for peptide purification because of its volatility,
efficiency and UV transparency at typical detection wavelengths (12,20), it was not an
ideal agent to separate the peptides in our study when AcCN was used as the organic
solvent (Figure 10a). Other ion-pairing agents were investigated with the following order
of hydrophobicity : HFBA > TFA > H3PO4 (13). TEAP buffer and 0.1% H3PO4 solution
gave similar resolutions, although TEAP buffer gaveslightly longer retention times.
HFBA, however, was an ineffective ion-pairing agent which could not separate the desired
cyclic peptide from the Tmg byproduct (Figure 10b). Except when HFBA was used as
the ion-pairing agent, the Tmg side product was eluted prior to the cyclic peptide(Figure
10 and Table 9.1). Since the Tmg side product is more polar than the cyclic peptide due
to additional acidic and basic residues in the molecule (Figure 7),it was retained less by
the hydrophobic RPC column.27
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Figure 10.Effects of ion-pairing agents on RPC. Sample: crude peptide A.Column:
Vydac. Mobile phase: solvent A= 0.1%x in H20, solvent B = 0.1%x in AcCN, where
a) x = TFA, b) x = HFBA, c) x= H3PO4 and d) solvent A = TEAP(I), solvent B = AcCN.
Flow rate: 1.5 mL/min. Gradient: 0% to 75% Bover 50 min.28
Effect of pH of the mobile phase
Changing the pH of the mobile phase can alter peptideresolution in RPC due to
changes in the ionization state of amino acid residues. Mostpeptides can be separated
at acidic or neutral pH (20). A lowerpH (< 3.0) is more favorable than higher pH (>
8.0), since at high pH the silanol sites on the surface of thesilica-based column are
ionized, which results in poor reproducibility and shortening of columnlife (13,19,20,26).
Comparison of the effects of a TEAP buffer at two different pHs,2.25 and 5.0, on the
elution profile of crude peptide A are shown in Figure 11 and R5values are listed in
Table 9.1. Increasing the pH to 5.0 adversely affected theseparations.
Effect of organic modifiers
An organic modifier is a water-miscible solvent added to the aqueoussolvent to
affect separation of peptides. The separation of peptides by RPC isbased on differences
in hydrophobicity. Therefore the polarity of organic modifiers can alterthe retention of
peptides.Since using TFA in AcCN did not give the best resolution for ourpeptides,
Me0H was examined as a possible organic solvent using both TFAand TEAP as ion-
pairing agents.
The retention times of the cyclic dynorphin A analogue andthe Tmg side product
in Me0H are longer than in AcCN for both ion-pairing agents(TFA and TEAP) (Figures
12.1 and 12.2, and Table 9.1).The overall hydrophobicity and viscosity of Me0H is
higher than AcCN (Table 7), and Me0H requires a longer time toelute the peptide from0.2
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0.0
a. pH 2.5, Rs = 103
cycl i c
00
0
00 0
0
rl
0
in
ri
0.o
0
C4
b. pH 5.0, Overlapping peaks
Retention time (min)
29
Figure 11.Effects of mobile phase pH on RPC. Sample: crude peptide A. Column:
Vydac. Mobile phase: solvent A = TEAP(I) at a) pH 2.5 and b) pH 5 solvent B = AcCN.
Flow rate: 1.5 mLimin. Gradient: 0% to 75% B over 50 min.30
the non-polar surface of the RPC column. Since Me0H has a higher UV cutoff (210 nm)
than AcCN (195 nm)(Table 7), the optimum absorption wavelength for peptides (214 nm)
(24) cannot be used when Me0H is an organic modifier and the peak heights from the
separation by Me0H are shorter than those from AcCN (Figure 12.1 and 12.2)Using
TFA as the ion-pairing agent, Me0H gave a better separation and higher Rs than AcCN
(Figure 12.1), however, TEAP (I) in AcCN provided superior results to TEAP (I) in
Me0H (Figure 12.2).
Table 7. Properties of AcCN and Me0H (15)
Dielectric constant Polarity Viscosity UV cutoff'
AcCN 37.5 6.2 0.37 195 nm
Me0H 32.6 6.6 0.60 210 nm
'UV cutofff is the wavelength at which the solvent has an absorbance of 1.0 absorbance
unit (AU).31
Retention time (min)
Figure 12.1.Effects of organic modifiers on RPC using TFA as ion-pairing agent.
Sample: crude peptide A. Column: Vydac. Mobile phase: solvent A= 0.1% TFA in
H2O, solvent B = 0.1% TFA in a) Me0H and b) AcCN. Flow rate: 1.5 mL/min.
Gradient: 0% to 75% B over 50 min.32
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Figure 12.2.Effects of organic modifiers on RPC using TEAP as ion-pairing agent.
Sample: crude peptide A. Column: Vydac. Mobilephase: solvent A = TEAP (I) pH 2.5,
solvent B = a) Me0H and b) AcCN. Flow rate:1.5 mL/min. Gradient: 0% to 75% B
over 50 min.33
Loading study on RPC
Resolution during peptide purifications depends on the amount of sample loaded
on the column. An analytical column can be used todetermine appropriate quantities that
can be loaded during a preparative run. Inorder to determine how much material could
be separated on a preparative column, a loading study of crude peptide A was performed.
The Zorbax column was chosen since this column has the same stationary phase as the
preparative column used in our laboratory. A lower concentration of TEAP (0.09 N)
(TEAP (II)) was used instead of TEAP (I) (0.25 N TEAP) in order to reduce the amounts
of phosphate salt generated in the mobile phase (27). A slower gradient of AcCN was
employed in TEAP II. TEAP II provided a smaller Rs value than TEAP I, however, the
cyclic peptide was better separated from the Tmg byproduct (Figure 13.1).The
chromatogram for an analytical sample (20 1.1g) of crude peptide A mixture separated by
using TEAP (II) on the Zorbax column is shown in Figure 13.2.
The analytical Zorbax column (4.6 mm ID) could separate the desired cyclic
peptide from the Tmg byproduct using 1 mg of crude peptide A (Figure 13.3a)which is
equivalent to 20 mg on the one inch diameter preparative column.The resolution
decreased some when loading of the column was increased to 3 mg of the crudemixture
(Figure 13.3b), but a reasonable separation was still obtained. Therefore, themaximum
capacity of the one inch diameter preparative column using these conditions is 50-60 mg.0.2 -
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Figure 13.1.Effects of concentration of TEAP and AcCN on RPC. Sample: crude
peptide A. Column: Vydac. Mobile phase: solvent A = a) TEAP (I)and b) TEAP (II)
pH 2.5, solvent B = a) AcCN and b) 40% A + 60% AcCN. Flow rate: 1.5 mL/min.
Gradient: 0% to 75% B over 50 min.Retention time (min)
Figure 13.2.A preliminary run of crude peptideA mixture (20 gg)on the Zorbax
column. Mobile phase: solvent A= TEAP (II) pH 2.5, solvent B = 40% A + 60% AcCN.
Flow rate: 1.5 mL/min. Gradient: 0%to 75% B over 50 min.36
Retention time (min)
Figure 13.3.Loading studies on RPC. Sample: crude peptide A a) 1 mg and b) 3 mg.
Column: Zorbax Pro. Mobile phase: solvent A = TEAP(II) pH 2.5, solvent B = solvent
A + 60% AcCN. Flow rate: 1.5 mL/min. Gradient: 0% to 75% B over 50 min.37
Ion exchange chromatography
IEC is an alternative mode for separation of peptides containing highly charged
acidic or basic amino acids.The cyclic dynorphin A analogues in this study carry
positive charges from the N-terminus and five basic amino acids at positions 6, 7, 9, 11
and 13 (Figure 7), whereas the Tmg and linear byproducts have one acidic residue and
one additional basic residue. The SCX column containingpolysulfoethyl aspartamide as
the stationary phase (Figure 8) resolves peptides by the ability of sulfonate groups to
retain positively charged peptides at neutral or lower pH (1).Therefore, ion exchange
chromatography using SCX column is a logical method for resolving the cyclic peptides
from the Tmg byproducts in the crude peptide mixtures. The separation of the cyclic
peptide from the linear byproducts using ion exchange chromatography was examined
using a phosphate buffer containing AcCN with a gradient of KCl to elute the peptides.
Method development using different pHs and organic solvents for separation on the SCX
column was done on a guard cartridge (4.6 x 50 mm) rather than on the analytical column
to reduce analysis time.
Effect of pH of the mobile phase
Ion exchange chromatography separates peptides by utilizing differences in their
net charge. The expression of the peptide's net charge depends onthe pH, e.g. in a basic
or neutral mobile phase N-terminal and side chainamino groups are not fully charged,38
while they are positively charged in an acidic solvent. Therefore it is apparent that pH
could have a large effect on the separation of the cyclic peptides from the Tmg
byproducts.
The ionization state of the cyclic peptide is the same at neutral or acidic pHs since
the D-aspartic acid residue is cyclized to give the lactam ring. At lower pH (3.0) the D-
aspartic acid side chain (pK. = 3.9) of the Tmg byproduct, however, is predominately in
the neutral form, while at higher pH (5.0) this residue is deprotonated. The net charge
of the cyclic peptide is +6 at both pHs (3.0 and 5.0), whereas, the charge of the Tmg
byproduct is +7 and +6 at pH 3.0 and 5.0, respectively. Thus the difference in the net
charge of the desired cyclic peptide (+6) and the Tmg byproduct (+7) at pH 3.0 should
enhance the separation.
The cyclic peptide was eluted from the SCX column prior to the Tmg byproduct
at pH 3.0 (Figure 14) since the cyclic peptide has a lower net charge (+6) thanthe Tmg
byproduct (+7),while at pH 5.0 overlapping peaks were obtained. Therefore, pH 3.0
was chosen for use in further experiments in this study.a.1-
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Figure 14.Effects of mobile phase pH on IEC. Sample: crude peptide A. Column:
SCX guard cartridge. Mobile phase: buffer A = 5 mM KH2PO4+25% AcCN at a) pH 3.0
and b) pH 5.0, solvent B = solvent A + 800 mM KC1. Flow rate: 1.5 mL/min. Gradient:
10% to 70% B over 12 min.40
Effect of organic modifiers
The mechanism of IEC is primarily electrostatic interactions between the solute
and the ion-exchange packing.The stationary phase exhibits some hydrophobic
characteristics, however, which results in poor peak shape and poor resolution (3).
A small amount of organic solvent, e.g. 10-15% of AcCN, in the mobile phase is
recommended to suppress the hydrophobicity of the IEC packing (3).A higher
concentration of AcCN (> 50%) promotes mixed-mode hydrophilic and ionic interactions
between peptides and the stationary phase, which can be useful for the separation of
peptides containing the same net charge (1,3). The resolution of peptides, however, may
either improve or decrease depending on the properties of each peptide. For example in
5 mM potassium phosphate buffer at pH 3.0, (3- endorphin (1-17) (net charge = +2) was
well separated from 13-endorphin (1-9) (net charge = +2) using 50% AcCN but not 25%
AcCN, whereas in the same mobile phase the separation of I3-endorphin (1-9) (net charge
= +2) from I3-endorphin (1-16) (net charge =+2) was better in 10% AcCN than in 25%
AcCN (1).The separation of crude peptide A mixture using different AcCN
concentrations is shown in Figure 15.1. The highest resolution value was obtained at 35%
AcCN. However, minor imprities eluted as shoulders on the main peaks at this AcCN
concentration, and therefore this condition was not examine further. Lower levels of
acetonitrile (10% and 25%) gave better separation of these minor impurities than the
higher level (35%) and 10% AcCN was selected to separate the peptides on the analytical
SCX column (Figure 15.2).0.1
0.0
Retention time (min)
Figure 15.1Effects of organic modifierson IEC. Sample: crude peptide A. Column:SCX guard cartridge. Mobilephase: solvent A = 5 mM KH2PO4+ x%AcCN pH 3.0, a)x = 10 b) x = 25 and c) x= 35, solvent B = solvent A + 800 mM KC1. Flow rate: 1.5 mL/min. Gradient:10% to 70% B over 12 min.0.2
0.0
42
Retention time (min)
Figure 15.2 The separation of crude peptide A mixture on the analytical SCX column.
Mobile phase: solvent A = 5 mM KH2PO4 + 10% AcCN pH 3.0, solvent B = solvent A
+ 800 mM KC1. Flow rate 1.5 mL/min. Gradient: 20% to 70% B over100 min.43
Loading study on SCX column
The optimized conditions from the method development, namelyphosphate buffer,
pH 3.0, containing 10% AcCN with an increasing salt gradient, wereused in a loading
study to determine the capacity of a preparative column.Results of the loading capacity
on the SCX column in Figure 16indicate that a 1 mg loading gave good resolution;
scaling the loading up to 5 mg caused some decrease inresolution, but still gave a
reasonable separation. The cyclic peptide and Tmg byproductcould not be resolved,
however, when the column was overloaded with 10 mg of crudepeptides. Therefore, the
loading capacity of a half inch diameter preparative SCX columnis approximately 50 mg.44
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Figure 16. Loading studies on SCX column. Sample: crude peptide A. a) 1 mg, b) 5 mg
and c) 10 mg. Column: SCX column. Mobile phase: solvent A = 5 mM KH2PO4 +10%
AcCN pH 3.0, solvent B = solvent A + 800 mM KCI. Flow rate: 1.5 mL/min. Gradient:
20% to 60% B over 80 min.45
Table 8.1. Retention times of purified peptides under the RPC conditions used for the
separation of crude peptide A.
Condition tcydic (min)' tTmg (min)2 tune., (min)3
Figure 10a 17.9 16.7 14.8
10b 25.3 25.3 24.4
10c 13.2 9.8 9.4
10d 14.7 11.3 11.3
lla 14.7 11.3 11.3
1 lb
4 4 4
12.1a 26.4 22.2 19.9
12.1b 17.9 16.0 16.5
12.2a 22.4 15.7 13.6
12.2b 14.7 11.3 11.3
13.1a 14.7 11.3 11.3
13.1b 19.6 13.8 10.7
13.2 22.0 16.2 12.9
1,2 "d3Retention time of purified cyclic peptide cyclo[D-Asp2,0m1Dyn A(1-13)NH2, Tmg
byproduct and linear byproduct, respectively.
"Very broad peak46
Table 8.2Retention times of purified peptides under the IEC conditions used for the
separation of crude peptide A.
Condition tcyclie (min)1 ttmg (min)2 tlinear (min)3
Figure 14a 6.0 6.5 5.8
14b 3.6 4.0 3.9
15.1a 7.0 7.7 7.2
15.1b 6.0 6.5 5.8
15.1c 4.6 5.4 7.1
15.2 31.3 36.6 38.1
1 '2 "d 3Re tendon time of purified cyclic peptide cyclo[D-Asp2,Orn5JDyn A(1-13)NH2, Tmg
byproduct and linear byproduct, respectively.47
Table 9.1.Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of crude peptide A mixture under various RPC conditions.
Condition tcyclic (min)' timg (min)2 A t(min)3 Rs4 Rs5
Figure 10a 18.2 16.2 2.0 4.7 1.8
10b
_6 6 _6 6 6
10c 12.8 9.9 2.9 8.6 3.2
10d 14.8 11.3 3.5 10.3 3.5
lla 14.8 11.3 3.5 10.3 3.5
1 lb
_6 _6 _6 6 6
12.1a 26.2 22.3 3.9 5.7 3.3
12.1b 18.2 16.2 2.0 4.7 1.8
12.2a 22.2 14.6 7.6 6.7 5.1
12.2b 14.8 11.3 3.5 10.3 3.5
13.1a 14.8 11.3 3.5 10.3 3.5
13.1b 19.3 14.1 5.2 7.7 3.7
13.2 22.1 16.4 5.7 11.2 5.7
13.3a 21.1 15.7 5.4 7.1 8.3
13.3b 30.2 72.6 7.6 3.7 5.4
and 2Retention of cyclic peptidend Tm2-5 byproduct, respectively.
3t
LudictTmg
4Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).
6Overlapping peaks.48
Table 9.2Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of crude peptide A mixture under various IEC conditions.
Condition tcychc (min)1 t,,8 (min)2 A t (min)3 Rs4 Rs5
Figure 14a 6.0 6.5 0.5 0.8 0.9
14b
_6 _6 _6 _6 6
15.1a 7.4 8.0 0.6 1.4 1.2
15.1b 6.0 6.5 0.5 0.8 0.9
15.1c 4.7 5.5 0.8 2.4 0.8
15.2 31.1 36.3 5.2 5.1 2.9
16a 28.3 34.3 6.1 2.4 5.3
16b 29.1 35.8 6.7 1.7 2.2
16c
_6 _6 _6 _6
I and2Retention time of cyclic peptide and Tmg byproduct, respectively.
3tTmgtcyclic
'Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).
6Overlapping peaks.49
CONCLUSIONS
The separation of the cyclic analogue of dynorphin A from the Tmg side product
can be achieved by either reverse phase or ion exchangechromatography. In RPC, the
Tmg byproduct was eluted prior to the desired cyclic peptide under all of the
chromatographic conditions examined except when HFBA was used as the ion-pairing
agent. Four possible solvent systems of RPC gave the bestresults, 0.1% TFA in aqueous
Me0H, 0.1% H3PO4 in aqueous AcCN, TEAP (I) in aqueous AcCN and TEAP(II) in 60%
AcCN (e.g. mobile phase 2, 4, 5 and 6, respectively). Using phosphoric acid as the ion-
pairing agent (mobile phase 4) or TEAP buffer (mobile phases 5 and 6)requires a
desalting step, whereas pure fractions can be obtained directly from 0.1% TFA inMe0H
(mobile phase 2). The loading capacity on the Zorbax column using mobile phase 6(0.09
N TEAP in 60% AcCN) is 1-3 mg, which is equivalent to 20-60 mg on the oneinch
preparative column available in our laboratory.
In IEC, a phosphate buffer, pH 3.0, containing 10% acetonitrile with anincreasing
gradient of KCl provided optimum conditions for the separation of crudepeptide A. The
amount of salt required to elute the cyclic peptide and Tmgbyproduct on SCX column
was 350-400 mM and the cyclic peptide waseluted before the Tmg byproduct. During
IEC, the loading capacity of the analytical SCX column was 5 mg, which isequivalent
to 50 mg on a half-inch preparative column.50
An advantage of RPC over IEC for preparative purification of peptides is that a
subsequent desalting step is not required if TFA is used as the ion pairing agent since
TFA is volatile.If a phosphate-containing buffer such as TEAP is used for RPC,
however, an additional desalting step is needed. A second advantage is that the mobile
phases used in RPC do not contain a high salt concentration, and therefore will not
damage standard steel HPLC systems.
The advantage of IEC over RPC is that the cyclic peptide is eluted prior to the
Tmg byproduct resulting in less contamination from IEC purification. However, the high
concentration of salt (400 mM KCI) requires a desalting step in the final purification and
the high percentage of salt can damage standard HPLC systems. Thus, a non-steel system
is preferred when using ion exchange chromatography.51
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Appendix A. Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of crude peptide A on different RPC columns under the same conditions as in
Figure 13.2 (TEAP (II) buffer, pH 2.5 in 60% AcCN).
Column tcy,, (min)1 tl(min)2 At (min)3 Rs4 Rs5
Vydac 19.3 14.1 5.2 7.7 3.7
Zorbax6 22.1 16.4 5.7 11.2 5.7
Dynamax 24.0 19.2 4.8 11.3 4.8
1 "d 2Re ten tion time of the cyclic peptide and the Tmg byproduct, respectively.
3tcyclictTing
4Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).
This column was used for Figure 13.2.55
Appendix B.Chromatogram of the separation of crude peptide B under the same
conditions as in Figure 13.2 (Zorbax column using TEAP (II) buffer, pH 2.5 in 60%
AcCN).
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Appendix C. Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of crude peptide B on different RPC columns under the same conditions as in
Figure 13.2 (TEAP (II) buffer, pH 2.5 in 60% AcCN).
Column tcych, (min)' tying (min)2 At (min)3 Rs4 Rs5
Vydac 16.4 12.7 3.7 5.5 2.2
Zorbax6 19.8 15.4 4.4 7.4 3.1
Dynamax 21.9 18.2 3.7 10.9 4.1
1"d2Retention time of the cyclic peptide and the Tmg byproduct, respectively.
3tcyclictTmg
4Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).
'This column was used for Figure 13.2.56
Appendix D.Chromatogram of the separation of crude peptide C under the same
conditions as in Figure 13.2 (Zorbax column using TEAP (H) buffer, pH 2.5 in 60%
AcCN).
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Appendix E. Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of crude peptide C on different RPC columns under the same conditions as in
Figure 13.2 (TEAP (II) buffer, pH 2.5 in 60% AcCN).
Column tcydic (min)1 trmg (min)2 At (min)3 Rs4 R35
Vydac 15.3 12.1 3.2 7.6 2.3
Zorbax6 21.4 14.5 6.9 13.6 6.9
Dynamax 23.7 17.8 5.9 17.4 6.6
1'Retention time of the cyclic peptide and the Tmg byproduct, respectively.
3f
'cyclictT
m, 4Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).
6This column was used in Figure 13.2.57
Appendix F. Resolution values (Rs) of the cyclic peptide and the Tmg byproduct for the
separation of different crude peptides on SCX column under the same conditions asin
Figure 15.2 (phosphate buffer, pH 3.0 containing 10% AcCN with KC1 gradient).
Crude peptide tcychc (min)' t,,8 (min)2 At (min)3 Rs4 Rs5
A 31.1 36.3 5.2 5.1 2.9
B 32.8 37.1 4.3 3.4 2.0
C 31.8 36.0 4.2 3.3 1.6
and'Retention time of the cyclic peptide and the Tmg byproduct, respectively.
3tTmgtcyclic
4Calculated by using peak width at half height (equation (b)).
5Calculated by using baseline peak width (equation (a)).58
Appendix G. Chromatogram of the separation of crude peptide B on SCX column under
the same conditions as in Figure 15.2 (phosphate buffer, pH 3.0 containing 10% AcCN
with KC1 gradient).
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Appendix H. Chromatogram of the separation of crude peptide C on SCX column under
the same conditions as in Figure 15.2 (phosphate buffer, pH 3.0 in 10% AcCN with KCl
gradient).
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Appendix I.Chromatogram of the separation of crude peptide A (45.9 mg) on the
preparative Zorbax Protein Plus (21 x 250 mm) using 0.1% TFA in aqueous Me0H.
Flow rate: 20 mL/min. Gradient: 20% to 50% over 30 min.
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Appendix J.Chromatogram of the separation of crude peptide A (17.9 mg) on the
preparative Zorbax Protein Plus (21 x 250 mm) using TEAP II buffer, pH 2.5 containing
60% AcCN. Flow rate: 20 mL/min. Gradient: 0% to 60% over 60 min. TEAP desalting
was done on Zorbax column using solvent system1 (Table 5). The salt was washed with
100% solvent A for 10 min and then the peptide was eluted with 18% solvent B. Flow
rate: 1.5 mL/min.
cyclic (1.1 mg)
Tmg (0.8mg)
I
Retention time (min)